» Articles » PMID: 2548487

Mode of Activation of Bovine Brain Inositol 1,4,5-trisphosphate 3-kinase by Calmodulin and Calcium

Overview
Journal Biochem J
Specialty Biochemistry
Date 1989 Jun 15
PMID 2548487
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of Ca2+ and calmodulin (CaM) on the activation of purified bovine brain Ins(1,4,5)P3 kinase was quantified and interpreted according to the model of sequential equilibria generally used for other calmodulin-stimulated systems. Two main conclusions can be drawn. (i) CaM.Ca3 and CaM.Ca4 together are the biologically active species in vitro, as is the case for the great majority of other calmodulin targets. (ii) These species bind in a non-co-operative way to the enzyme with an affinity constant of 8.23 x 10(9) M-1, i.e. approx 10-fold higher than for most calmodulin-activated target enzymes. The dose-response curve of the activation of Ins(1,4,5)P3 kinase by calmodulin is not significantly impaired by melittin and trifluoperazine, whereas under very similar assay conditions the half-maximal activation of bovine brain cyclic AMP phosphodiesterase requires over 30-50-fold higher concentrations of CaM when 1 microM melittin or 20 microM-trifluoperazine is present in the assay medium. Similarly, 1 microM of the anti-calmodulin peptides seminalplasmin and gramicidin S, as well as 20 microM of N-(6-aminohexyl)-5-chloro-1-naphthalene-sulphonamide (W7), do not inhibit the activation process. These data suggest that binding and activation of Ins(1,4,5)P3 kinase require surface sites of calmodulin which are different from those involved in the binding of most other target enzymes or of model peptides.

Citing Articles

Astrocyte Intracellular Caand TrkB Signaling in the Hippocampus Could Be Involved in the Beneficial Behavioral Effects of Antidepressant Treatment.

Ferreira F, Cupido A, Catalin B, Silva Jr W, Kirchhoff F, Del-Bel E Neurotox Res. 2021; 39(3):860-871.

PMID: 33616872 DOI: 10.1007/s12640-021-00334-0.


Membrane association, localization and topology of rat inositol 1,4,5-trisphosphate 3-kinase B: implications for membrane traffic and Ca2+ homoeostasis.

Soriano S, Thomas S, High S, Griffiths G, DSantos C, Cullen P Biochem J. 1997; 324 ( Pt 2):579-89.

PMID: 9182721 PMC: 1218469. DOI: 10.1042/bj3240579.


Purification and properties of D-myo-inositol 1,4,5-trisphosphate 3-kinase from bovine iris sphincter smooth muscle: effects of protein phosphorylation in vitro and in intact muscle.

Wang X, Akhtar R, Abdel-Latif A Biochem J. 1995; 308 ( Pt 3):1009-16.

PMID: 8948463 PMC: 1136823. DOI: 10.1042/bj3081009.


Inositol trisphosphate metabolism in Saccharomyces cerevisiae: identification, purification and properties of inositol 1,4,5-trisphosphate 6-kinase.

Estevez F, Pulford D, Stark M, Carter A, Downes C Biochem J. 1994; 302 ( Pt 3):709-16.

PMID: 7945194 PMC: 1137289. DOI: 10.1042/bj3020709.


Rat brain inositol 1,4,5-trisphosphate 3-kinase. Ca2(+)-sensitivity, purification and antibody production.

Takazawa K, Lemos M, Delvaux A, Lejeune C, Dumont J, Erneux C Biochem J. 1990; 268(1):213-7.

PMID: 1693074 PMC: 1131414. DOI: 10.1042/bj2680213.


References
1.
Comte M, Maulet Y, Cox J . Ca2+-dependent high-affinity complex formation between calmodulin and melittin. Biochem J. 1983; 209(1):269-72. PMC: 1154084. DOI: 10.1042/bj2090269. View

2.
Cox J, Comte M, Stein E . Activation of human erythrocyte Ca2+-dependent Mg2+-activated ATPase by calmodulin and calcium: quantitative analysis. Proc Natl Acad Sci U S A. 1982; 79(14):4265-9. PMC: 346651. DOI: 10.1073/pnas.79.14.4265. View

3.
Berridge M, Dawson R, Downes C, Heslop J, Irvine R . Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J. 1983; 212(2):473-82. PMC: 1152070. DOI: 10.1042/bj2120473. View

4.
Burger D, Stein E, Cox J . Free energy coupling in the interactions between Ca2+, calmodulin, and phosphorylase kinase. J Biol Chem. 1983; 258(23):14733-9. View

5.
Hidaka H, Tanaka T . Naphthalenesulfonamides as calmodulin antagonists. Methods Enzymol. 1983; 102:185-94. DOI: 10.1016/s0076-6879(83)02019-4. View